OVID

Ovid Therapeutics Inc

Jun 24 • 04:00PM ET

2.50

+0.18 7.76 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: INCY BMRN VKTX KRYS KYMR NUVL RYTM AXSM MDGL NBIX

| Held by: XBI VTI VXF AVSC LABU SURI PRFZ BSVO DFAS DFMC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.24	Insider Own	9.52%	Shs Outstand	186.64M	Perf Week	5.93%
Market Cap	466.60M	Forward P/E	-	EPS next Y	-0.53	Insider Trans	-0.11%	Shs Float	168.88M	Perf Month	1.21%
Enterprise Value	324.15M	PEG	-	EPS next Q	-0.12	Inst Own	58.84%	Short Float	6.30%	Perf Quarter	3.31%
Income	-24.17M	P/S	65.53	EPS this Y	-110.00%	Inst Trans	40.54%	Short Ratio	4.20	Perf Half Y	70.07%
Sales	7.12M	P/B	2.11	EPS next Y	-10.42%	ROA	-15.73%	Short Interest	10.63M	Perf YTD	53.37%
Book/sh	1.19	P/C	3.00	EPS next 5Y	-	ROE	-18.77%	52W High	3.11 -19.48%	Perf Year	728.64%
Cash/sh	0.83	P/FCF	-	EPS past 3/5Y	32.53% 29.81%	ROIC	-11.51%	52W Low	0.29 768.06%	Perf 3Y	-32.98%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.99% -10.48%	Gross Margin	97.26%	Volatility	7.88% 7.38%	Perf 5Y	-41.72%
Dividend TTM	-	EV/Sales	45.53	EPS Y/Y TTM	30.81%	Oper. Margin	-670.25%	ATR (14)	0.17	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.17	Sales Y/Y TTM	1199.64%	Profit Margin	-339.31%	RSI (14)	53.35	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.17	EPS Q/Q	13.39%	SMA20	3.97%	Beta	0.21	Target Price	5.50
Payout	-	Debt/Eq	0.07	Sales Q/Q	-100.00%	SMA50	-3.37%	Rel Volume	1.11	Prev Close	2.32
Employees	23	LT Debt/Eq	0.06	Earnings	May 12 BMO	SMA200	31.83%	Avg Volume	2.53M	Price	2.50
IPO	May 05, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.83% -100.00%	Trades		Volume	2,805,101	Change	7.76%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)